__NUXT_JSONP__("/drugs/Burixafor", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1191448-17-5",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with receptor binding and hematopoietic stem cell-mobilization activities. Burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation; this may induce the mobilization of hematopoietic stem and progenitor cells from the bone marrow into blood. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor (GPCR) gene family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types; CXCL12\u002FCXCR4 interaction induces retention of hematopoietic cells in the bone marrow.",fdaUniiCode:"2G17Y0Q20G",identifier:"C88323",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C107589"],synonyms:["BURIXAFOR",a,"Phosphonic Acid, p-(2-(4-(6-Amino-2-(((trans-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)-4-pyrimidinyl)-1-piperazinyl)ethyl)-","TG-0054"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FBurixafor",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Burixafor","","2021-10-30T13:46:55.173Z")));